Search research articles
Contact Us
Filters
Showing results (71-80 of 114) with videos related to
Page
of 12
Sort By:
The Oncologist
|
May 25, 2012
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
Wen-Yi Shau, Yu-Yun Shao, Yi-Chun Yeh, et al.
American Journal of Cancer Research
|
January 13, 2025
Continuing anti-EGFR monoclonal antibody after secondary resection significantly prolongs overall survival for patients with metastatic colorectal cancer who were responsive to first-line anti-EGFR monoclonal antibody plus chemotherapy doublet
Yao-Yu Hsieh, Yu-Li Su, Feng-Che Kuan, et al.
Cells
|
August 7, 2021
<i>Eg5</i> as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
Yu-Yun Shao, Nai-Yun Sun, Yung-Ming Jeng, et al.
The Oncologist
|
June 8, 2012
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy
Zhong-Zhe Lin, Chiun Hsu, Fu-Chang Hu, et al.
Oncotarget
|
November 22, 2017
Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
Yu-Yun Shao, Min-Shu Hsieh, Han-Yu Wang, et al.
Oncology
|
January 25, 2012
Survival of patients with small cell lung carcinoma in Taiwan
Yu-Hsuan Kuo, Zhong-Zhe Lin, Yen-Yun Yang, et al.
Liver Cancer
|
April 26, 2019
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
Li-Chun Lu, Yi-Hsuan Lee, Chun-Jung Chang, et al.
Clinical Colorectal Cancer
|
March 15, 2015
Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan
Yu-Yun Shao, Chih-Hung Hsu, Kun-Huei Yeh, et al.
Journal of Hepatology
|
January 25, 2026
Revisiting Prophylactic Corticosteroids to Mitigate Severe Immune-Related Adverse Events in Hepatocellular Carcinoma
Ying-Chun Shen, David J Pinato, Tsung-Hao Liu, et al.
Hepatology International
|
August 20, 2022
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment
Ching-Tso Chen, Yin-Hsun Feng, Chia-Jui Yen, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 114) with videos related to
Sort By:
Page
of 12
The Oncologist
|
May 25, 2012
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
Wen-Yi Shau, Yu-Yun Shao, Yi-Chun Yeh, et al.
American Journal of Cancer Research
|
January 13, 2025
Continuing anti-EGFR monoclonal antibody after secondary resection significantly prolongs overall survival for patients with metastatic colorectal cancer who were responsive to first-line anti-EGFR monoclonal antibody plus chemotherapy doublet
Yao-Yu Hsieh, Yu-Li Su, Feng-Che Kuan, et al.
Cells
|
August 7, 2021
<i>Eg5</i> as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
Yu-Yun Shao, Nai-Yun Sun, Yung-Ming Jeng, et al.
The Oncologist
|
June 8, 2012
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy
Zhong-Zhe Lin, Chiun Hsu, Fu-Chang Hu, et al.
Oncotarget
|
November 22, 2017
Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
Yu-Yun Shao, Min-Shu Hsieh, Han-Yu Wang, et al.
Oncology
|
January 25, 2012
Survival of patients with small cell lung carcinoma in Taiwan
Yu-Hsuan Kuo, Zhong-Zhe Lin, Yen-Yun Yang, et al.
Liver Cancer
|
April 26, 2019
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
Li-Chun Lu, Yi-Hsuan Lee, Chun-Jung Chang, et al.
Clinical Colorectal Cancer
|
March 15, 2015
Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan
Yu-Yun Shao, Chih-Hung Hsu, Kun-Huei Yeh, et al.
Journal of Hepatology
|
January 25, 2026
Revisiting Prophylactic Corticosteroids to Mitigate Severe Immune-Related Adverse Events in Hepatocellular Carcinoma
Ying-Chun Shen, David J Pinato, Tsung-Hao Liu, et al.
Hepatology International
|
August 20, 2022
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment
Ching-Tso Chen, Yin-Hsun Feng, Chia-Jui Yen, et al.
Page
of 12